Estrella Immunopharma, Inc.ESLANASDAQ
Loading
| Metric | Jun 22 | Dec 22 | Jun 24 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Income | -2 | -2 | -7 |
| Net Income | -2 | -1 | -7 |
| EBITDA | -0 | -1 | -7 |
| EPS Diluted | -0.29 | -0.17 | -0.21 |
| Metric | Jun 22 | Dec 22 | Jun 24 |
|---|---|---|---|
| Cash & Equivalents | 4 | 0 | 4 |
| Total Current Assets | 5 | 0 | 4 |
| Total Assets | 5 | 10 | 4 |
| Total Current Liabilities | 1 | 1 | 0 |
| Total Liabilities | 6 | 3 | 0 |
| Total Equity | -1 | 7 | 4 |
| Total Debt | 0 | 0 | 0 |
| Net Debt | -4 | 0 | -4 |
| Metric | Jun 22 | Dec 22 | Jun 24 |
|---|---|---|---|
| Operating Cash Flow | -1 | -1 | -16 |
| Capital Expenditure | 0 | 0 | -0 |
| Free Cash Flow | -1 | -1 | -16 |
| Stock-Based Comp | 0 | 0 | 1 |
| Net Change in Cash | 4 | -0 | 2 |